These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 31111337)
1. Correction to: 3D skeletal uptake of Belal SL; Sadik M; Kaboteh R; Hasani N; Enqvist O; Svärm L; Kahl F; Simonsen J; Poulsen MH; Ohlsson M; Høilund-Carlsen PF; Edenbrandt L; Trägårdh E EJNMMI Res; 2019 May; 9(1):44. PubMed ID: 31111337 [TBL] [Abstract][Full Text] [Related]
2. 3D skeletal uptake of Lindgren Belal S; Sadik M; Kaboteh R; Hasani N; Enqvist O; Svärm L; Kahl F; Simonsen J; Poulsen MH; Ohlsson M; Høilund-Carlsen PF; Edenbrandt L; Trägårdh E EJNMMI Res; 2017 Dec; 7(1):15. PubMed ID: 28210997 [TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
4. Does Measurement of First-Order and Heterogeneity Parameters Improve Response Assessment of Bone Metastases in Breast Cancer Compared to SUV Azad GK; Cousin F; Siddique M; Taylor B; Goh V; Cook GJR Mol Imaging Biol; 2019 Aug; 21(4):781-789. PubMed ID: 30250989 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. Etchebehere EC; Araujo JC; Fox PS; Swanston NM; Macapinlac HA; Rohren EM J Nucl Med; 2015 Aug; 56(8):1177-84. PubMed ID: 26069307 [TBL] [Abstract][Full Text] [Related]
6. Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT. Kairemo K; Joensuu T Diagnostics (Basel); 2015 Oct; 5(4):413-27. PubMed ID: 26854163 [TBL] [Abstract][Full Text] [Related]
7. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer. Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446 [TBL] [Abstract][Full Text] [Related]
8. Unusual Soft Tissue Uptake of F-18 Sodium Fluoride in Three Patients Undergoing F-18 NaF PET/CT Bone Scans for Prostate Cancer. Hawkins AS; Howard BA Nucl Med Mol Imaging; 2017 Sep; 51(3):274-276. PubMed ID: 28878857 [TBL] [Abstract][Full Text] [Related]
9. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686 [TBL] [Abstract][Full Text] [Related]
10. The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer. Kulshrestha RK; Vinjamuri S; England A; Nightingale J; Hogg P J Nucl Med Technol; 2016 Dec; 44(4):217-222. PubMed ID: 27634981 [TBL] [Abstract][Full Text] [Related]
11. Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting Yoon J; Ballas L; Desai B; Jadvar H World J Nucl Med; 2017; 16(3):229-236. PubMed ID: 28670183 [TBL] [Abstract][Full Text] [Related]
12. (18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer. Zukotynski KA; Kim CK; Gerbaudo VH; Hainer J; Taplin ME; Kantoff P; den Abbeele AD; Seltzer S; Sweeney CJ Am J Nucl Med Mol Imaging; 2015; 5(1):72-82. PubMed ID: 25625029 [TBL] [Abstract][Full Text] [Related]
13. Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer. Apolo AB; Lindenberg L; Shih JH; Mena E; Kim JW; Park JC; Alikhani A; McKinney YY; Weaver J; Turkbey B; Parnes HL; Wood LV; Madan RA; Gulley JL; Dahut WL; Kurdziel KA; Choyke PL J Nucl Med; 2016 Jun; 57(6):886-92. PubMed ID: 26795292 [TBL] [Abstract][Full Text] [Related]
14. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study. Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438 [TBL] [Abstract][Full Text] [Related]
15. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [TBL] [Abstract][Full Text] [Related]
16. Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT. Rohren EM; Etchebehere EC; Araujo JC; Hobbs BP; Swanston NM; Everding M; Moody T; Macapinlac HA J Nucl Med; 2015 Oct; 56(10):1507-12. PubMed ID: 26135112 [TBL] [Abstract][Full Text] [Related]
17. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice. Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282 [TBL] [Abstract][Full Text] [Related]
18. Uptake of Radium-223 Dichloride and Early [ Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074 [TBL] [Abstract][Full Text] [Related]
19. (18)F Sodium Fluoride PET/CT in Patients with Prostate Cancer: Quantification of Normal Tissues, Benign Degenerative Lesions, and Malignant Lesions. Oldan JD; Hawkins AS; Chin BB World J Nucl Med; 2016; 15(2):102-8. PubMed ID: 27134560 [TBL] [Abstract][Full Text] [Related]
20. F-18 fluoride uptake in primary breast cancer. Sarikaya I; Sharma P; Sarikaya A Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]